Study details
Enrolling now
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Fox Chase Cancer Center
NCT IDNCT05454280ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
880
Study length
about 6.1 years
Ages
18+
Locations
1 site in PA
About this study
This trial is testing whether intensified post-discharge surveillance, compared to standard post-discharge surveillance, improves outcomes for patients undergoing high-risk elective major cancer surgery. Eligible adult patients will be randomly assigned to either the intensified or standard post-discharge care and monitored for specific events during a defined period after their surgery.
Based on ClinicalTrials.gov records.
What participants do
- 1.Undergo Intensified post-discharge surveillance
- 2.Undergo Standard post-discharge surveillance
PhasePhase 3
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low6%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Procedures
monitoring
Body systems
Oncology